CDSCO initiates action against J&J over baby powder
Draws samples of baby powder from the company's Baddi plant in Himachal Pradesh
Central Drugs Standard Control Organisation…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 105
Browsing Category
Latest Updates
GSK to split after striking Pfizer consumer health deal
GSK said the deal laid the foundation for the creation of two new UK-based global companies focussed on pharma/vaccines and…
Strides to get $42 m from escrow account after winning arbitration on Agila sale
Strides Pharma Science and its wholly-owned subsidiary completed the sale to Mylan Laboratories and Mylan Institutional of Agila…
Glenmark forays into branded dermatology segment in US
The branded portfolio for the US market will be developed and commercialised by Glenmark Therapeutics USA
European Commission okays Mylan, Biocon’s biosimilar of cancer drug
Ogivri is indicated for the treatment of patients with HER2 positive early breast cancer, metastatic breast cancer and metastatic…
Aptar Pharma to exhibit latest innovations in drug delivery devices at Pharmapack 2019 in Paris
The company will showcase two of their newest product launches, PureHale and QuickStart Injectables
Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Oil
Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its…
Pfizer’s cut-price version of Avastin wins EU panel greenlight
Pfizer's Zirabev is a cheaper version to Roche Holding's leading cancer drug Avastin
Lupin receives US FDA approval for Clobazam tabs
The drug is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients two years…
CX Partners acquires equity stake in Veeda Clinical Research
The investors will make additional investments in the company over a period of time to fund the growth requirements of the company